Addiction Medicine Journal Club
We believe that addiction is a disease that can be treated, and we want to help you stay up to date with the latest research that you can use in your addiction medicine practice.
Listen On
Episodes
We believe that addiction is a disease that can be treated, and we want to help you stay up to date with the latest research that you can use in your addiction medicine practice.
In episode 59 we discuss
outpatient low-dose initiation of buprenorphine.
Suen LW, Chiang AY, Jones BLH, Soran CS, Geier M, Snyder HR, Neuhaus J, Myers JJ, Knight KR, Bazazi AR, Coffin PO. Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl. JAMA Netw Open. 2025 Jan 2;8(1):e2456253.
We also discuss impulse control dysregulation from ropinerole, and the new non-opioid painkiller, suzetrigine.
BBC:Prescription medication made me a gambling addict
Grall-Bronnec M, et al.Dopamine agonists and impulse control disorders: a complex association. DrugSaf. 2018;41(1):19-75.
FDA:FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
Vertex Pharmaceuticals: Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After
Abdominoplasty or Bunionectomy
—
This podcast offers category 1
and MATE-ACT CME credits through MI CARES and Michigan State
University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.
CME:https://micaresed.org/courses/podcast-addiction-medicine-journal-club/
—
- Original theme music:composed and performed by Benjamin Kennedy
- Audio editing: Michael Bonanno
- Executive producer:Dr. Patrick Beeman
- A podcast from Ars Longa Media
—
Learn more about your ad choices. Visit megaphone.fm/adchoices
Cast and Crew
